Neuroradiology Research Group
Neuroradiological diagnosis of brain diseases is as an essential part of, and often the basis for treatment of neurological diseases at Oslo University Hospital. Computer tomography (CT), Nuclear medicine techniques (NM) and magnetic resonance imaging (MRI) is presently the mainstay of imaging diagnosis for the vast majority of neurological diseases. Advanced MRI techniques has especially contributed to improved diagnostic brain imaging of degenerative, inflammatory, vascular and tumor diseases. Oslo University Hospital has comprehensive clinical activity on brain disorders/diseases, and many of the members of the group memebers already participate in interdisciplinary teams together with physicists, neurosurgeons, neurologists, oncologists, and other clinicians. Many of the members of this research group has existing international research collaborations.
The main aim of this group is to gather active researchers, PhD students and other research-interested colleagues from the Department of Radiology and Nuclear Medicine at Oslo University Hospital. We also invite colleagues from other hospitals in our region. By learning about the projects that are currently ongoing within our group there will be a potential for new collaborations between participants within this group either through sharing of new methods or radiological techniques. Also new research ideas may evolve from such meetings. Thus we will stimulate new research collaborations and projects through getting to know each other and each others projects better. This way knowledge and ideas from the members of the group can contribute to research questions that can only be solved by interested researchers in a radiological environment.
The members of this group focuses on several different research topics within neuroradiology.
Some of the main themes are; Brain tumor, Multiple Sclerosis, neurodegenerative diseases, normal pressure hydrocephalus/CSF diseases, vascular diseases including stroke. In addition we are involved in other topics like deep brain stimulation and neurodevelopmental disorders.
Early phase drug development: From idea to concept
Feb 3, 2017
Feb 2, 2017
Oncolytic peptide LTX-315; the road from basic science to clinical trials
Jan 26, 2017
MRI-Based Classification Models in Prediction of Mild Cognitive Impairment and Dementia in Late-Life Depression
Front Aging Neurosci, 9, 13
Within- and between-session reproducibility of GABA measurements with MR spectroscopy
J Magn Reson Imaging (in press)